Drug intelligence / Profile preview

aurintricarboxylic acid

Development stage
Preclinical
Modality
Small Molecules
Administration
None (research Use Only; Not Clinically Administered)
01

Overview

Aurintricarboxylic acid is a synthetic aromatic carboxylic acid known for its potent inhibition of protein-nucleic acid interactions, notably inhibiting ribonuclease and topoisomerase II by blocking nucleic acid binding. It acts as a stable polymeric free radical in aqueous solution, inhibits translation initiation, and is widely used as a research tool to suppress apoptosis and protein biosynthesis in biological systems. Aurintricarboxylic acid has antiviral activity in vitro against viruses including influenza A, HIV, SARS, MERS, SARS-CoV-2, and demonstrates activity against drug-resistant cancer cells by inhibiting translation initiation and cell proliferation. Its ammonium salt is used in chemical assays as the reagent aluminon for aluminum quantitation. Despite broad research applications, it is not approved or used clinically as a pharmaceutical agent.[1][2][3][5][7]

Brand names
aluminon (for ammonium salt)chrome violet CG (for trisodium salt)
Other names
aurintricarboxylic acidaurintricarbonic acidaurinetricarboxylic acidTIMTEC-BB SBB005410
02

Targets

GRIA2 (AMPA receptor subunit GluA2)CAPN (Schistosoma calpain large subunit family)MEKTEAD (TEAD family)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)TOP2A (DNA topoisomerase II)ERBB4 (Erb-b2 receptor tyrosine kinase 4)PLpro (Papain-like protease)

Beyond the preview

Go deeper on aurintricarboxylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aurintricarboxylic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call